BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34302663)

  • 1. Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.
    Anzai T; Hara H; Chanthra N; Sadahiro T; Ieda M; Hanazono Y; Uosaki H
    Methods Mol Biol; 2021; 2320():247-259. PubMed ID: 34302663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-in of large reporter genes in human cells via CRISPR/Cas9-induced homology-dependent and independent DNA repair.
    He X; Tan C; Wang F; Wang Y; Zhou R; Cui D; You W; Zhao H; Ren J; Feng B
    Nucleic Acids Res; 2016 May; 44(9):e85. PubMed ID: 26850641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing using CRISPR/Cas9-based knock-in approaches in zebrafish.
    Albadri S; Del Bene F; Revenu C
    Methods; 2017 May; 121-122():77-85. PubMed ID: 28300641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of the CRISPR-Cas9 System in Drosophila Cultured Cells to Introduce Fluorescent Tags into Endogenous Genes.
    Bosch JA; Knight S; Kanca O; Zirin J; Yang-Zhou D; Hu Y; Rodiger J; Amador G; Bellen HJ; Perrimon N; Mohr SE
    Curr Protoc Mol Biol; 2020 Mar; 130(1):e112. PubMed ID: 31869524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing and clonal isolation of human induced pluripotent stem cells using CRISPR/Cas9.
    Yumlu S; Stumm J; Bashir S; Dreyer AK; Lisowski P; Danner E; Kühn R
    Methods; 2017 May; 121-122():29-44. PubMed ID: 28522326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient homology-directed gene editing by CRISPR/Cas9 in human stem and primary cells using tube electroporation.
    Xu X; Gao D; Wang P; Chen J; Ruan J; Xu J; Xia X
    Sci Rep; 2018 Aug; 8(1):11649. PubMed ID: 30076383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of genome-edited pluripotent stem cells and mice by CRISPR/Cas.
    Horii T; Hatada I
    Endocr J; 2016; 63(3):213-9. PubMed ID: 26743444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing in Human Induced Pluripotent Stem Cells (hiPSCs).
    Higo S; Hikoso S; Miyagawa S; Sakata Y
    Methods Mol Biol; 2021; 2320():235-245. PubMed ID: 34302662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CRISPR/Cas9 for the Modification of the Mouse Genome.
    Klimke A; Güttler S; Kuballa P; Janzen S; Ortmann S; Flora A
    Methods Mol Biol; 2019; 1953():213-230. PubMed ID: 30912024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Mediated Fluorescent Tagging of Endogenous Proteins in Human Pluripotent Stem Cells.
    Sharma A; Toepfer CN; Ward T; Wasson L; Agarwal R; Conner DA; Hu JH; Seidman CE
    Curr Protoc Hum Genet; 2018 Jan; 96():21.11.1-21.11.20. PubMed ID: 29364519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-Step Generation of Seamless Luciferase Gene Knockin Using CRISPR/Cas9 Genome Editing in Human Pluripotent Stem Cells.
    Li M; Hunt JFVS; Bhattacharyya A; Zhao X
    Methods Mol Biol; 2019; 1942():61-69. PubMed ID: 30900175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene editing in mouse zygotes using the CRISPR/Cas9 system.
    Wefers B; Bashir S; Rossius J; Wurst W; Kühn R
    Methods; 2017 May; 121-122():55-67. PubMed ID: 28263886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
    Vermersch E; Jouve C; Hulot JS
    Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and Derivation of Multi-Reporter Pluripotent Stem Cell Lines via CRISPR/Cas9n-Mediated Homology-Directed Repair.
    Dettmer R; Naujok O
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e116. PubMed ID: 32628328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation of Cas9 protein/sgRNA into early pronuclear zygotes generates non-mosaic mutants in the mouse.
    Hashimoto M; Yamashita Y; Takemoto T
    Dev Biol; 2016 Oct; 418(1):1-9. PubMed ID: 27474397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards mastering CRISPR-induced gene knock-in in plants: Survey of key features and focus on the model Physcomitrella patens.
    Collonnier C; Guyon-Debast A; Maclot F; Mara K; Charlot F; Nogué F
    Methods; 2017 May; 121-122():103-117. PubMed ID: 28478103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Transgenic Mice Using CRISPR /Cas9 Technology.
    El Marjou F; Jouhanneau C; Krndija D
    Methods Mol Biol; 2021; 2214():125-141. PubMed ID: 32944907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of Mouse Model (KI and CKO) via Easi-CRISPR.
    Shola DTN; Yang C; Han C; Norinsky R; Peraza RD
    Methods Mol Biol; 2021; 2224():1-27. PubMed ID: 33606203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.